| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | Jul 2, 2025 | Athira Pharma, Inc. | CEO | Sell | 47.5 | -25,123 | -6.78% | ✗ | $7.4K |
| Dec 31, 2024 | Jan 3, 2025 | Athira Pharma, Inc. | CEO | Sell | 46.3 | -25,107 | -8.74% | ✗ | $14.1K |
| Sep 3, 2024 | Sep 5, 2024 | Athira Pharma, Inc. | CEO | Sell | 85.0 | +14,968 | 9.12% | ✗ | $2.8K |
| Jan 4, 2024 | Feb 16, 2024 | Athira Pharma, Inc. | CEO | Sell | 91.3 | +15,180 | 10.19% | ✗ | $14K |
| Jan 4, 2024 | Jan 8, 2024 | Athira Pharma, Inc. | CEO | Sell | 91.3 | +15,180 | 10.19% | ✗ | $14K |
| May 18, 2022 | Jun 24, 2022 | Athira Pharma, Inc. | CEO | Sell | 86.3 | +12,797 | 9.45% | ✗ | $21.4K |